| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Rock Edwin is a Chief Medical Officer at CRESCENT BIOPHARMA, INC.. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $12.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21, 2024 | CBIO Crescent Biopharma, Inc. | Chief Medical Officer | Buy | 305,000 | $0.26 | $78,824.50 | +32.4% | -33.9% | -41.7% | |
| Sep 22, 2023 | CBIO Crescent Biopharma, Inc. | Chief Medical Officer | Buy | 65,403 | $1.38 | $90,256.14 | +10.0% | +51.1% | -88.3% | |
| Dec 22, 2022 | CBIO Crescent Biopharma, Inc. | Chief Medical Officer | Buy | 110,000 | $2.25 | $247,500.00 | +55.0% | -38.9% | +12.4% | |
| Nov 15, 2022 | CBIO Crescent Biopharma, Inc. | Chief Medical Officer | Buy | 200,000 | $1.55 | $309,000.00 | +200.0% | +122.4% | -18.2% |